Skip to Content

TEVA 7334 (Mycophenolate Mofetil 250 mg)

Pill with imprint TEVA 7334 is Blue & Orange, Capsule-shape and has been identified as Mycophenolate Mofetil 250 mg. It is supplied by Teva Pharmaceuticals USA.

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; organ transplant, rejection prophylaxis; graft-versus-host disease and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 7334

Mycophenolate mofetil 250 mg TEVA 7334
Mycophenolate mofetil 250 mg TEVA 7334
Mycophenolate mofetil 250 mg TEVA 7334

Mycophenolate Mofetil

Imprint
TEVA 7334
Strength
250 mg
Color
Blue & Orange
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Selective immunosuppressants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
National Drug Code (NDC)
00093-7334

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.